Dubuque Bank & Trust CO Biogen Inc. Transaction History

Dubuque Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 10, 2019	SELL	$219.29 - $241.72 $4,605 - $5,076	-21 Closed	0 $0
Q1 2019 Apr 02, 2019	BUY	$216.71 - $338.96 $1,516 - $2,372	7 Added 50.0%	21 $5,000
Q3 2018 Oct 30, 2018	SELL	$293.51 - $383.83 $880 - $1,151	-3 Reduced 17.65%	14 $5,000
Q2 2018 Jul 17, 2018	SELL	$257.52 - $306.91 $57,941 - $69,054	-225 Reduced 92.98%	17 $5,000
Q1 2018 May 10, 2018	BUY	$260.13 - $367.91 $780 - $1,103	3 Added 1.26%	242 $66,000
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $61,528 - $68,916	200 Added 512.82%	239 $76,000
Q3 2017 Oct 13, 2017	BUY	$281.15 - $329.69 $10,964 - $12,857	39	39 $12,000

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Dubuque Bank & Trust CO with notifications on news.